2011
DOI: 10.1002/jbio.201100022
|View full text |Cite
|
Sign up to set email alerts
|

Confocal laser endomicroscopy in gastrointestinal diseases

Abstract: Confocal laser endomicroscopy (CLE) is a novel endoscopic technique permitting in vivo microscopy (optical biopsies) of the gastrointestinal mucosa. CLE has been studied in a multitude of diseases of the upper and lower gastrointestinal tract, including Barrett's esophagus, gastric inflammation and cancer, celiac disease, colorectal adenoma and carcinoma, and inflammatory bowel diseases. CLE has recently evolved and been studied for bile duct and liver imaging. CLE has shown overall high accuracy and enabled s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
32
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 67 publications
(34 citation statements)
references
References 54 publications
0
32
0
2
Order By: Relevance
“…Both have been evaluated as endoscopeintegrated and probe-based devices. [7][8][9][10][11] Probes can be used more flexibly with most of the new generation highdefinition endoscopes. These probes are available 'on demand' for introduction through the working channel without the need for a dedicated endoscope.…”
Section: Introductionmentioning
confidence: 99%
“…Both have been evaluated as endoscopeintegrated and probe-based devices. [7][8][9][10][11] Probes can be used more flexibly with most of the new generation highdefinition endoscopes. These probes are available 'on demand' for introduction through the working channel without the need for a dedicated endoscope.…”
Section: Introductionmentioning
confidence: 99%
“…CLE allows high-resolution, microanatomical analysis of tissue ('optical biopsies') in real time during endoscopy [1,2]. The utility of this new technology is highlighted by its capacity to differentiate tissue types and entities on the basis of histologic characteristics of the mucosa and submucosal vasculature [3].…”
Section: Introductionmentioning
confidence: 99%
“…Since the first description in 2004 [1], the number of diseases studied with this technique has been steadily growing [2][3][4][5][6][7][8][9]. Trials with CLE have moved from feasibility studies in different parts of the endoscopically accessible areas of the gastrointestinal tract towards inflammatory and (pre-) neoplastic diseases that are often only incompletely appreciated by random biopsies.…”
Section: Introductionmentioning
confidence: 99%